SUN PHARMACEUTICAL INDUSTRIES LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,533 INR | -0.44% |
|
-4.27% | +21.81% |
| Apr. 12 | Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade | MT |
| Apr. 12 | Sun Pharmaceutical's Dadra, India Unit Gets 'Official Action Indicated' Status from US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
2024-05-23
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
37
Last Close Price
1,540
INR
Average target price
1,553
INR
Spread / Average Target
+0.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.81% | 44.25B | |
| +19.12% | 22.33B | |
| +10.80% | 13.36B | |
| +4.03% | 13.24B | |
| +39.27% | 11.27B | |
| -6.68% | 7.15B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.00% | 5.24B | |
| +7.31% | 4.61B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Launches Acne Cream in US
